ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

KTRA Company Profile and Key Details

NASDAQ : KTRA

Kintara Therapeutics, Inc.

$0.22

-0.0145-6.31%

At Close 4:00 PM

Not Actively Trading

62.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

KTRA Stock Price Chart

Stock Price Today

Kintara Therapeutics, Inc. (KTRA) stock declined over -6.31%, trading at $0.22 on NASDAQ, down from the previous close of $0.23. The stock opened at $0.24, fluctuating between $0.20 and $0.24 in the recent session.

Stock Snapshot

0.2299

Prev. Close

0.24

Open

11.99M

Market Cap

55.66M

Number of Shares

0.2049

Day Low

0.2356

Day High

-0.019232142857142857

P/E Ratio

2.85%

Free Float in %

-11.2

EPS (TTM)

-0.04

Book Value

-1.57

Cash Flow per Share

3.55M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Oct 17, 2024	0.24	0.24	0.20	0.22	3.55M
Oct 16, 2024	8.23	8.34	6.66	8.05	171.61K
Oct 15, 2024	6.61	8.40	6.61	7.94	139.65K
Oct 14, 2024	6.30	7.17	6.23	6.93	53.86K
Oct 11, 2024	6.22	6.30	6.17	6.22	11.22K
Oct 10, 2024	6.43	6.44	6.01	6.17	41.61K
Oct 09, 2024	6.58	6.72	6.37	6.51	12.97K
Oct 08, 2024	6.82	6.89	6.19	6.61	38.69K
Oct 07, 2024	7.05	7.29	6.79	6.90	24.43K
Oct 04, 2024	6.65	7.75	6.65	7.38	96.89K
Oct 03, 2024	6.89	6.89	6.51	6.53	29.75K
Oct 02, 2024	6.56	6.82	6.23	6.69	30.88K
Oct 01, 2024	6.51	6.61	6.16	6.39	32.98K
Sep 30, 2024	6.79	6.91	6.58	6.82	33.33K
Sep 27, 2024	6.42	7.33	5.95	7.16	168.31K
Sep 26, 2024	7.35	7.63	6.33	6.78	1.97M
Sep 25, 2024	5.60	5.95	5.60	5.86	34.34K
Sep 24, 2024	5.83	5.83	5.65	5.67	21.19K
Sep 23, 2024	5.91	5.94	5.60	5.71	19.45K
Sep 20, 2024	6.65	6.65	5.53	6.09	81.75K

Contact Details

San Diego, CA 92130

United States

Website: https://www.kintara.comContact: 858 350 4364

About Company

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current Kintara Therapeutics, Inc. (KTRA) stock price?

Kintara Therapeutics, Inc. (NASDAQ: KTRA) stock price is $0.22 in the last trading session. During the trading session, KTRA stock reached the peak price of $0.24 while $0.20 was the lowest point it dropped to. The percentage change in KTRA stock occurred in the recent session was -6.31% while the dollar amount for the price change in KTRA stock was -$0.01.

KTRA's industry and sector of operation?

The NASDAQ listed KTRA is part of Biotechnology industry that operates in the broader Healthcare sector. Kintara Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KTRA?

Mr. Greg A. Johnson
Acting Head of Operations
Mr. Robert E. Hoffman B.B.A., C.P.A., CPA
Pres, Chief Executive Officer, Chief Financial Officer & Chairman
Mr. Robert E. Hoffman B.B.A., CPA, CPA
Pres, Chief Executive Officer, Chief Financial Officer & Chairman
Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Founder
Mr. Scott Praill B.Sc., C.P.A., CA, CPA, BSc
Chief Financial Officer & Sec.
Mr. Scott Praill B.Sc., BSc, C.P.A., CA, CPA
Chief Financial Officer & Sec.

How KTRA did perform over past 52-week?

KTRA's closing price is 5.12% higher than its 52-week low of $0.20 where as its distance from 52-week high of $26.21 is -99.18%.

How many employees does KTRA have?

Number of KTRA employees currently stands at 1.

Link for KTRA official website?

Official Website of KTRA is: https://www.kintara.com

How do I contact KTRA?

KTRA could be contacted at phone 858 350 4364 and can also be accessed through its website. KTRA operates from 12707 High Bluff Drive, San Diego, CA 92130, United States.

How many shares of KTRA are traded daily?

KTRA stock volume for the day was 3.55M shares. The average number of KTRA shares traded daily for last 3 months was 83.39K.

What is the market cap of KTRA currently?

The market value of KTRA currently stands at $11.99M with its latest stock price at $0.22 and 55.66M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	1
Beta	0.81
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology